Metformin Alters mRNA Expression of <i>FOXP3</i>, <i>RORC</i>, and <i>TBX21</i> and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes

Metformin Alters mRNA Expression of <i>FOXP3</i>, <i>RORC</i>, and <i>TBX21</i> and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes

COVID-19 remains a significant global concern, particularly for individuals with type 2 diabetes who face an elevated risk of hospitalization and mortality. Metformin, a primary treatment for type 2 diabetes, demonstrates promising pleiotropic properties that may substantially mitigate disease sever...

Full description

Bibliographic Details
Main Authors: Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Oleksandr Kamyshnyi
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Viruses
Subjects:
COVID-19
metformin
Treg
T cell
Th17
F/B ratio
Online Access:https://www.mdpi.com/1999-4915/16/2/281

Internet

https://www.mdpi.com/1999-4915/16/2/281

Similar Items